| Income Statement |
| Operating Expenses | 5.41M |
|
| Research and Development Expense | 1.49M |
| Selling, General and Administrative Expense | 3.93M |
| Operating Income | -5.41M |
| Interest Expense | 141.28K |
| Net Income | -5.87M |
| Net Income Common Stock | -5.87M |
| Net Income Common Stock (USD) | -5.87M |
| Consolidated Income | -5.87M |
| Earning Before Interest & Taxes (EBIT) | -5.73M |
| Earning Before Interest & Taxes (USD) | -5.73M |
| Weighted Average Shares | 13.28M |
| Balance Sheet |
| Cash and Equivalents | 28.40M |
| Cash and Equivalents (USD) | 28.40M |
| Trade and Non-Trade Receivables | 38.45K |
| Current Assets | 30.21M |
| Property, Plant & Equipment Net | 2.86M |
| Total Assets | 33.07M |
| Debt Current | 5.32M |
| Total Debt | 6.29M |
| Current Liabilities | 8.63M |
| Debt Non-Current | 968.46K |
| Total Liabilities | 9.60M |
| Accumulated Retained Earnings (Deficit) | -147.56M |
| Shareholders Equity | 23.47M |
| Shareholders Equity (USD) | 23.47M |
| Assets Non-Current | 2.86M |
| Total Debt (USD) | 6.29M |
| Liabilities Non-Current | 968.46K |
| Trade and Non-Trade Payables | 1.99M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 98.24K |
| Net Cash Flow from Financing | 8.48M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.51M |
| Capital Expenditure | -67.08K |
| Issuance (Purchase) of Equity Shares | 9.14M |
| Issuance (Repayment) of Debt Securities | -660.00K |
| Net Cash Flow from Investing | -67.08K |
| Net Cash Flow from Operations | -5.90M |
| Share Based Compensation | 362.23K |